Eli Lilly & Co. (LLY) Tops Q1 EPS Views; Maintains Outlook
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,148.11 -0.38%
EPS Growth %: +40.3%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +40.3%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.24, $0.08 better than the analyst estimate of $1.16. Revenue for the quarter came in at $5.84 million versus the consensus estimate of $5.7 billion.
Maintains outlook.
Maintains outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eli Lilly (LLY) PT Raised to $1,284 at Guggenheim
- Lilly to present diabetes and obesity drug data at EASD 2026
- Nucor projects Q3 2026 earnings above prior year, below estimates
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
